Board Change • Jun 01
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. MD & Director S Ganeshkumar was the last director to join the board, commencing their role in 2026. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Price Target Changed • May 27
Price target decreased by 18% to ₹302 Down from ₹366, the current price target is an average from 4 analysts. New target price is 36% above last closing price of ₹222. Stock is down 49% over the past year. The company is forecast to post a net loss per share of ₹3.17 next year compared to a net loss per share of ₹17.70 last year. Announcement • May 26
Chemplast Sanmar Limited, Annual General Meeting, Aug 07, 2026 Chemplast Sanmar Limited, Annual General Meeting, Aug 07, 2026. Reported Earnings • May 26
Full year 2026 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2026 results: ₹17.70 loss per share (further deteriorated from ₹6.98 loss in FY 2025). Revenue: ₹42.5b (down 2.2% from FY 2025). Net loss: ₹2.80b (loss widened 154% from FY 2025). Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) exceeded analyst estimates by 4.3%. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance. Announcement • May 19
Chemplast Sanmar Limited to Report Q4, 2026 Results on May 25, 2026 Chemplast Sanmar Limited announced that they will report Q4, 2026 results on May 25, 2026 Board Change • Apr 16
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. Non-Executive Independent Director Vikram Hosangady was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Buy Or Sell Opportunity • Mar 23
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 4.0% to ₹258. The fair value is estimated to be ₹325, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.1% over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Feb 27
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 14% to ₹246. The fair value is estimated to be ₹307, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.1% over the last 3 years. Meanwhile, the company became loss making. Price Target Changed • Feb 10
Price target decreased by 12% to ₹380 Down from ₹434, the current price target is an average from 4 analysts. New target price is 34% above last closing price of ₹283. Stock is down 35% over the past year. The company is forecast to post a net loss per share of ₹21.00 next year compared to a net loss per share of ₹6.98 last year. Reported Earnings • Feb 09
Third quarter 2026 earnings: EPS and revenues miss analyst expectations Third quarter 2026 results: ₹7.45 loss per share (further deteriorated from ₹3.06 loss in 3Q 2025). Revenue: ₹8.35b (down 21% from 3Q 2025). Net loss: ₹1.19b (loss widened 144% from 3Q 2025). Revenue missed analyst estimates by 26%. Earnings per share (EPS) also missed analyst estimates by 28%. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 89 percentage points per year, which is a significant difference in performance. Announcement • Feb 02
Chemplast Sanmar Limited to Report Q3, 2026 Results on Feb 07, 2026 Chemplast Sanmar Limited announced that they will report Q3, 2026 results at 12:08 PM, Indian Standard Time on Feb 07, 2026 New Risk • Jan 13
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (7.4% operating cash flow to total debt). Minor Risk Share price has been volatile over the past 3 months (7.0% average weekly change). Price Target Changed • Nov 18
Price target decreased by 14% to ₹474 Down from ₹553, the current price target is an average from 4 analysts. New target price is 45% above last closing price of ₹327. Stock is down 33% over the past year. The company is forecast to post a net loss per share of ₹5.55 next year compared to a net loss per share of ₹6.98 last year. Announcement • Nov 11
Chemplast Sanmar Limited to Report Q2, 2026 Results on Nov 13, 2025 Chemplast Sanmar Limited announced that they will report Q2, 2026 results at 12:08 PM, Indian Standard Time on Nov 13, 2025 Announcement • Oct 28
Chemplast Sanmar Limited to Report Q2, 2026 Results on Nov 04, 2025 Chemplast Sanmar Limited announced that they will report Q2, 2026 results on Nov 04, 2025 Price Target Changed • Oct 13
Price target increased by 9.9% to ₹553 Up from ₹503, the current price target is an average from 4 analysts. New target price is 51% above last closing price of ₹366. Stock is down 26% over the past year. The company is forecast to post earnings per share of ₹3.00 next year compared to a net loss per share of ₹6.98 last year. Announcement • Jul 22
Chemplast Sanmar Limited to Report Q1, 2026 Results on Jul 28, 2025 Chemplast Sanmar Limited announced that they will report Q1, 2026 results on Jul 28, 2025 Reported Earnings • Jul 22
Full year 2025 earnings: EPS misses analyst expectations Full year 2025 results: ₹6.98 loss per share (improved from ₹10.02 loss in FY 2024). Revenue: ₹43.5b (up 11% from FY 2024). Net loss: ₹1.10b (loss narrowed 30% from FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 65%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 122 percentage points per year, which is a significant difference in performance. Announcement • May 14
Chemplast Sanmar Limited, Annual General Meeting, Aug 07, 2025 Chemplast Sanmar Limited, Annual General Meeting, Aug 07, 2025. Reported Earnings • May 14
Full year 2025 earnings: EPS misses analyst expectations Full year 2025 results: ₹6.92 loss per share (improved from ₹10.02 loss in FY 2024). Revenue: ₹43.9b (up 12% from FY 2024). Net loss: ₹1.10b (loss narrowed 30% from FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 65%. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 114 percentage points per year, which is a significant difference in performance. Announcement • May 10
Chemplast Sanmar Limited to Report Q4, 2025 Results on May 13, 2025 Chemplast Sanmar Limited announced that they will report Q4, 2025 results on May 13, 2025 Buy Or Sell Opportunity • Apr 30
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 12% to ₹412. The fair value is estimated to be ₹516, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Apr 07
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 18% to ₹409. The fair value is estimated to be ₹517, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Feb 11
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 8.3% to ₹434. The fair value is estimated to be ₹545, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Meanwhile, the company became loss making. Reported Earnings • Feb 08
Third quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behind Third quarter 2025 results: ₹3.06 loss per share (improved from ₹5.65 loss in 3Q 2024). Revenue: ₹10.7b (up 20% from 3Q 2024). Net loss: ₹488.2m (loss narrowed 45% from 3Q 2024). Revenue missed analyst estimates by 4.8%. Earnings per share (EPS) exceeded analyst estimates by 7.3%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 112 percentage points per year, which is a significant difference in performance. Announcement • Jan 30
Chemplast Sanmar Limited to Report Q3, 2025 Results on Feb 07, 2025 Chemplast Sanmar Limited announced that they will report Q3, 2025 results on Feb 07, 2025 Reported Earnings • Nov 06
Second quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behind Second quarter 2025 results: ₹1.95 loss per share (down from ₹1.65 profit in 2Q 2024). Revenue: ₹10.0b (up 1.6% from 2Q 2024). Net loss: ₹312.6m (down 220% from profit in 2Q 2024). Revenue missed analyst estimates by 6.6%. Earnings per share (EPS) exceeded analyst estimates by 35%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 99 percentage points per year, which is a significant difference in performance. Announcement • Oct 31
Chemplast Sanmar Limited to Report Q2, 2025 Results on Nov 05, 2024 Chemplast Sanmar Limited announced that they will report Q2, 2025 results on Nov 05, 2024 Announcement • Aug 02
Chemplast Sanmar Limited to Report Q1, 2025 Results on Aug 07, 2024 Chemplast Sanmar Limited announced that they will report Q1, 2025 results on Aug 07, 2024 Reported Earnings • Jul 15
Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2024 results: ₹10.02 loss per share (down from ₹9.64 profit in FY 2023). Revenue: ₹39.2b (down 21% from FY 2023). Net loss: ₹1.58b (down 204% from profit in FY 2023). Revenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) missed analyst estimates by 31%. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Chemicals industry in India. Announcement • Jun 21
Chemplast Sanmar Limited announced a financing transaction Chemplast Sanmar Limited announced a private placement to issue equity shares or any other securities convertible into equity shares including warrants or otherwise and/or any other eligible securities through preferential allotment on June 19, 2024. The transaction is subject to approval of the shareholders and receipt of regulatory/statutory and other approvals as applicable. Price Target Changed • Jun 19
Price target increased by 8.8% to ₹582 Up from ₹535, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of ₹581. Stock is up 30% over the past year. The company is forecast to post earnings per share of ₹14.05 next year compared to a net loss per share of ₹10.02 last year. Buy Or Sell Opportunity • May 28
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 1.5% to ₹476. The fair value is estimated to be ₹395, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 3.5% over the last 3 years. Meanwhile, the company became loss making. Announcement • May 23
Chemplast Sanmar Limited, Annual General Meeting, Aug 08, 2024 Chemplast Sanmar Limited, Annual General Meeting, Aug 08, 2024, at 16:20 Indian Standard Time. Reported Earnings • May 21
Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2024 results: ₹10.02 loss per share (down from ₹9.64 profit in FY 2023). Revenue: ₹40.0b (down 19% from FY 2023). Net loss: ₹1.58b (down 204% from profit in FY 2023). Revenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) missed analyst estimates by 31%. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Announcement • May 16
Chemplast Sanmar Limited to Report Q4, 2024 Results on May 20, 2024 Chemplast Sanmar Limited announced that they will report Q4, 2024 results on May 20, 2024 Reported Earnings • Feb 13
Third quarter 2024 earnings: EPS and revenues miss analyst expectations Third quarter 2024 results: ₹5.65 loss per share (down from ₹1.72 profit in 3Q 2023). Revenue: ₹9.01b (down 24% from 3Q 2023). Net loss: ₹893.8m (down 429% from profit in 3Q 2023). Revenue missed analyst estimates by 14%. Earnings per share (EPS) also missed analyst estimates by 95%. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Announcement • Feb 03
Chemplast Sanmar Limited to Report Q3, 2024 Results on Feb 12, 2024 Chemplast Sanmar Limited announced that they will report Q3, 2024 results on Feb 12, 2024 Price Target Changed • Nov 04
Price target decreased by 7.1% to ₹568 Down from ₹612, the current price target is an average from 3 analysts. New target price is 27% above last closing price of ₹447. Stock is up 22% over the past year. The company is forecast to post earnings per share of ₹12.40 for next year compared to ₹9.64 last year. Reported Earnings • Nov 03
Second quarter 2024 earnings released: EPS: ₹1.65 (vs ₹2.44 in 2Q 2023) Second quarter 2024 results: EPS: ₹1.65 (down from ₹2.44 in 2Q 2023). Revenue: ₹10.2b (down 14% from 2Q 2023). Net income: ₹260.5m (down 32% from 2Q 2023). Profit margin: 2.5% (down from 3.2% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in India. Announcement • Oct 26
Chemplast Sanmar Limited to Report Q2, 2024 Results on Nov 02, 2023 Chemplast Sanmar Limited announced that they will report Q2, 2024 results on Nov 02, 2023 Price Target Changed • Aug 14
Price target decreased by 8.1% to ₹585 Down from ₹637, the current price target is an average from 3 analysts. New target price is 32% above last closing price of ₹443. Stock is down 3.6% over the past year. The company is forecast to post earnings per share of ₹36.00 for next year compared to ₹9.64 last year. Buying Opportunity • Aug 10
Now 23% undervalued after recent price drop Over the last 90 days, the stock is down 1.8%. The fair value is estimated to be ₹564, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Earnings per share has grown by 7.2%. For the next 3 years, revenue is forecast to grow by 12% per annum. Earnings is also forecast to grow by 42% per annum over the same time period. Announcement • Aug 03
Chemplast Sanmar Limited to Report Q1, 2024 Results on Aug 10, 2023 Chemplast Sanmar Limited announced that they will report Q1, 2024 results on Aug 10, 2023 Reported Earnings • Jul 19
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: EPS: ₹9.64 (down from ₹43.66 in FY 2022). Revenue: ₹49.4b (down 16% from FY 2022). Net income: ₹1.52b (down 77% from FY 2022). Profit margin: 3.1% (down from 11% in FY 2022). Revenue missed analyst estimates by 2.7%. Earnings per share (EPS) also missed analyst estimates by 31%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 10.0% growth forecast for the Chemicals industry in India. Announcement • May 10
Chemplast Sanmar Limited Announces Resignation of Amarnath Ananthanarayanan to Board of Directors Chemplast Sanmar Limited announced that Dr. Amarnath Ananthanarayanan, Non-Executive Non Independent Director, has resigned from Board of Directors of the Company with effect from May 09, 2023, due to his other pre-occupations. Date of Cessation: May 09, 2023. Reported Earnings • Feb 12
Third quarter 2023 earnings: EPS and revenues exceed analyst expectations Third quarter 2023 results: EPS: ₹1.72 (down from ₹14.98 in 3Q 2022). Revenue: ₹11.9b (down 18% from 3Q 2022). Net income: ₹271.4m (down 89% from 3Q 2022). Profit margin: 2.3% (down from 16% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue exceeded analyst estimates by 5.5%. Earnings per share (EPS) also surpassed analyst estimates by 91%. Revenue is forecast to grow 9.3% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Announcement • Feb 05
Chemplast Sanmar Limited to Report Q3, 2023 Results on Feb 11, 2023 Chemplast Sanmar Limited announced that they will report Q3, 2023 results at 12:08 PM, Indian Standard Time on Feb 11, 2023 Price Target Changed • Nov 16
Price target decreased to ₹623 Down from ₹753, the current price target is an average from 2 analysts. New target price is 61% above last closing price of ₹388. Stock is down 39% over the past year. The company is forecast to post earnings per share of ₹12.10 for next year compared to ₹43.66 last year. Board Change • Nov 16
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 1 experienced director. No highly experienced directors. Non-Executive Director Amar Ananthanarayanan is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Major Estimate Revision • Nov 12
Consensus EPS estimates fall by 47% The consensus outlook for earnings per share (EPS) in 2023 has deteriorated. 2023 revenue forecast decreased from ₹56.9b to ₹51.7b. EPS estimate also fell from ₹22.80 per share to ₹12.10 per share. Net income forecast to shrink 34% next year vs 25% growth forecast for Chemicals industry in India . Consensus price target down from ₹753 to ₹623. Share price rose 4.7% to ₹383 over the past week. Reported Earnings • Nov 05
Second quarter 2023 earnings: EPS exceeds analyst expectations Second quarter 2023 results: EPS: ₹2.44 (down from ₹10.51 in 2Q 2022). Revenue: ₹12.1b (down 28% from 2Q 2022). Net income: ₹385.4m (down 75% from 2Q 2022). Profit margin: 3.2% (down from 9.0% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates. Revenue is forecast to grow 7.9% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Price Target Changed • Oct 14
Price target decreased to ₹753 Down from ₹843, the current price target is an average from 2 analysts. New target price is 89% above last closing price of ₹398. Stock is down 48% over the past year. The company is forecast to post earnings per share of ₹22.80 for next year compared to ₹43.66 last year. Major Estimate Revision • Aug 16
Consensus EPS estimates fall by 49% The consensus outlook for earnings per share (EPS) in 2023 has deteriorated. 2023 revenue forecast decreased from ₹59.7b to ₹56.9b. EPS estimate also fell from ₹44.50 per share to ₹22.80 per share. Net income forecast to shrink 33% next year vs 20% growth forecast for Chemicals industry in India . Consensus price target down from ₹880 to ₹843. Share price fell 2.2% to ₹460 over the past week. Reported Earnings • Aug 07
First quarter 2023 earnings released: EPS: ₹2.57 (vs ₹6.48 in 1Q 2022) First quarter 2023 results: EPS: ₹2.57 (down from ₹6.48 in 1Q 2022). Revenue: ₹14.3b (up 8.4% from 1Q 2022). Net income: ₹405.9m (down 55% from 1Q 2022). Profit margin: 2.8% (down from 6.8% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the next year, revenue is expected to shrink by 4.9% compared to a 14% growth forecast for the industry in India. Announcement • Jul 30
Chemplast Sanmar Limited to Report Q1, 2023 Results on Aug 05, 2022 Chemplast Sanmar Limited announced that they will report Q1, 2023 results on Aug 05, 2022 Valuation Update With 7 Day Price Move • Jun 17
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₹393, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 23x in the Chemicals industry in India. Reported Earnings • May 13
Full year 2022 earnings: EPS exceeds analyst expectations Full year 2022 results: EPS: ₹43.66 (up from ₹30.60 in FY 2021). Revenue: ₹58.9b (up 55% from FY 2021). Net income: ₹6.49b (up 58% from FY 2021). Profit margin: 11% (in line with FY 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 2.2%. Over the next year, revenue is forecast to grow 1.6%, compared to a 20% growth forecast for the industry in India. Announcement • May 12
Chemplast Sanmar Limited, Annual General Meeting, Jun 24, 2022 Chemplast Sanmar Limited, Annual General Meeting, Jun 24, 2022. Agenda: To consider the appointment of M/ s B S R & Co. LLP as the Statutory Auditors of the Company for a period of 5 years from the conclusion of the ensuing 38th Annual General Meeting till the conclusion of 43rd Annual General Meeting. Announcement • May 07
Chemplast Sanmar Limited to Report Q4, 2022 Results on May 10, 2022 Chemplast Sanmar Limited announced that they will report Q4, 2022 results on May 10, 2022 Board Change • Apr 27
High number of new directors There are 6 new directors who have joined the board in the last 3 years. Independent Director Prasad Menon was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Announcement • Apr 22
Chemplast Sanmar Limited Announces Demise of N Sankar, Chairman Emeritus Chemplast Sanmar Limited announced the passing away of Mr. N Sankar, Chairman Emeritus, on April 17, 2022 and consequently he ceased to be chairman Emeritus of the company with effect from that date. Reported Earnings • Jan 30
Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind Third quarter 2022 results: EPS: ₹14.98 (down from ₹29.39 in 3Q 2021). Revenue: ₹14.5b (down 50% from 3Q 2021). Net income: ₹2.37b (down 40% from 3Q 2021). Profit margin: 16% (up from 14% in 3Q 2021). Revenue missed analyst estimates by 14%. Earnings per share (EPS) exceeded analyst estimates by 19%. Over the next year, revenue is forecast to grow 11%, compared to a 19% growth forecast for the industry in India. Valuation Update With 7 Day Price Move • Jan 27
Investor sentiment deteriorated over the past week After last week's 15% share price decline to ₹520, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 27x in the Chemicals industry in India. Simply Wall St's valuation model estimates the intrinsic value at ₹393 per share. Reported Earnings • Nov 04
Second quarter 2022 earnings released: EPS ₹10.51 (vs ₹29.39 in 2Q 2021) The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹16.7b (down 43% from 2Q 2021). Net income: ₹1.51b (down 62% from 2Q 2021). Profit margin: 9.0% (down from 14% in 2Q 2021). Valuation Update With 7 Day Price Move • Oct 06
Investor sentiment improved over the past week After last week's 18% share price gain to ₹718, the stock trades at a trailing P/E ratio of 27.7x. Average trailing P/E is 20x in the Chemicals industry in India. Executive Departure • Sep 04
Chief Financial Officer Meenakshisundaram Chandrasekar has left the company On the 31st of August, Meenakshisundaram Chandrasekar's tenure as Chief Financial Officer ended. We don't have any record of a personal shareholding under Meenakshisundaram's name. A total of 3 executives have left over the last 12 months.